Literature DB >> 383236

Purification and Best Department of Medical Research, University of Toronto, Ont., Canada.

B R Glick, R M Green, M C Ganoza.   

Abstract

Factor EF-P is a nonribosomal (soluble) protein of Escherichia coli that stimulates peptide bond synthesis when certain aminoacyl-tRNA analogues are used. The purification of this protein to apparent homogeneity is described here. EF-P has a molecular weight of about 21 000, a Stokes radius of 27 A (1A = 0.1 nm), and a frictional coefficient of 1.48, suggesting an asymmetric structure. By this and a number of other criteria, EF-P is a new factor that controls peptide bond formation during protein biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 383236

Source DB:  PubMed          Journal:  Can J Biochem        ISSN: 0008-4018


  5 in total

1.  A proposed role for IF-3 and EF-T in maintaining the specificity of prokaryotic initiation complex formation.

Authors:  M C Ganoza; C Cunningham; D G Chung; T Neilson
Journal:  Mol Biol Rep       Date:  1991-02       Impact factor: 2.316

2.  Extragenic Suppression of Elongation Factor P Gene Mutant Phenotypes in Erwinia amylovora.

Authors:  Sara M Klee; Judith P Sinn; Aleah C Holmes; Brian L Lehman; Teresa Krawczyk; Kari A Peter; Timothy W McNellis
Journal:  J Bacteriol       Date:  2019-05-08       Impact factor: 3.490

3.  Cloning, sequencing and overexpression of the gene for prokaryotic factor EF-P involved in peptide bond synthesis.

Authors:  H Aoki; S L Adams; D G Chung; M Yaguchi; S E Chuang; M C Ganoza
Journal:  Nucleic Acids Res       Date:  1991-11-25       Impact factor: 16.971

4.  Isolation and point of action of a factor from Escherichia coli required to reconstruct translation.

Authors:  M C Ganoza; C Cunningham; R M Green
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

5.  Predicting the pathway involved in post-translational modification of elongation factor P in a subset of bacterial species.

Authors:  Marc Bailly; Valérie de Crécy-Lagard
Journal:  Biol Direct       Date:  2010-01-13       Impact factor: 4.540

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.